| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Division of Endocrinology & Metabolism, Center for Osteoporosis & Metabolic Bone Diseases, University of Arkansas for Medical Sciences, and the Central Arkansas Veterans Healthcare System, Little Rock, Arkansas 72205, USA
The adult skeleton regenerates by temporary cellular structures that comprise teams of juxtaposed osteoclasts and osteoblasts and replace periodically old bone with new. A considerable body of evidence accumulated during the last decade has shown that the rate of genesis of these two highly specialized cell types, as well as the prevalence of their apoptosis, is essential for the maintenance of bone homeostasis; and that common metabolic bone disorders such as osteoporosis result largely from a derangement in the birth or death of these cells. The purpose of this article is 3-fold: 1) to review the role and the molecular mechanism of action of regulatory molecules, such as cytokines and hormones, in osteoclast and osteoblast birth and apoptosis; 2) to review the evidence for the contribution of changes in bone cell birth or death to the pathogenesis of the most common forms of osteoporosis; and 3) to highlight the implications of bone cell birth and death for a better understanding of the mechanism of action and efficacy of present and future pharmacotherapeutic agents for osteoporosis.
This article has been cited by other articles:
![]() |
M. Di Rocco, F. Giona, F. Carubbi, S. Linari, F. Minichilli, R. O. Brady, G. Mariani, and M. D. Cappellini A new severity score index for phenotypic classification and evaluation of responses to treatment in type I Gaucher disease Haematologica, August 1, 2008; 93(8): 1211 - 1218. [Abstract] [Full Text] [PDF] |
||||
![]() |
S E Papapoulos and R C Schimmer Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate Postgrad. Med. J., June 1, 2008; 84(992): 307 - 312. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Nerenz, M. L. Martowicz, and J. W. Pike An Enhancer 20 Kilobases Upstream of the Human Receptor Activator of Nuclear Factor-{kappa}B Ligand Gene Mediates Dominant Activation by 1,25-Dihydroxyvitamin D3 Mol. Endocrinol., May 1, 2008; 22(5): 1044 - 1056. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Dufour, X. Holy, and P. J. Marie Transforming growth factor-{beta} prevents osteoblast apoptosis induced by skeletal unloading via PI3K/Akt, Bcl-2, and phospho-Bad signaling Am J Physiol Endocrinol Metab, April 1, 2008; 294(4): E794 - E801. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sneve, N. Emaus, R. M. Joakimsen, and R. Jorde The association between serum parathyroid hormone and bone mineral density, and the impact of smoking: the Tromso Study Eur. J. Endocrinol., March 1, 2008; 158(3): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tam, V. Trembovler, V. Di Marzo, S. Petrosino, G. Leo, A. Alexandrovich, E. Regev, N. Casap, A. Shteyer, C. Ledent, et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling FASEB J, January 1, 2008; 22(1): 285 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horsch, H. de Wet, M. M. Schuurmans, F. Allie-Reid, A. C. B. Cato, J. Cunningham, J. M. Burrin, F. S. Hough, and P. A. Hulley Mitogen-Activated Protein Kinase Phosphatase 1/Dual Specificity Phosphatase 1 Mediates Glucocorticoid Inhibition of Osteoblast Proliferation Mol. Endocrinol., December 1, 2007; 21(12): 2929 - 2940. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vega, N. M. Maalouf, and K. Sakhaee The Role of Receptor Activator of Nuclear Factor-{kappa}B (RANK)/RANK Ligand/Osteoprotegerin: Clinical Implications J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4514 - 4521. [Abstract] [Full Text] [PDF] |
||||
![]() |
M M Conradie, H de Wet, D D R Kotze, J M Burrin, F S Hough, and P A Hulley Vanadate prevents glucocorticoid-induced apoptosis of osteoblasts in vitro and osteocytes in vivo J. Endocrinol., November 1, 2007; 195(2): 229 - 240. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Manolagas and M. Almeida Gone with the Wnts: {beta}-Catenin, T-Cell Factor, Forkhead Box O, and Oxidative Stress in Age-Dependent Diseases of Bone, Lipid, and Glucose Metabolism Mol. Endocrinol., November 1, 2007; 21(11): 2605 - 2614. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. BAB Regulation of Skeletal Remodeling by the Endocannabinoid System Ann. N.Y. Acad. Sci., November 1, 2007; 1116(1): 414 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Almeida, L. Han, M. Martin-Millan, L. I. Plotkin, S. A. Stewart, P. K. Roberson, S. Kousteni, C. A. O'Brien, T. Bellido, A. M. Parfitt, et al. Skeletal Involution by Age-associated Oxidative Stress and Its Acceleration by Loss of Sex Steroids J. Biol. Chem., September 14, 2007; 282(37): 27285 - 27297. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Almeida, L. Han, M. Martin-Millan, C. A. O'Brien, and S. C. Manolagas Oxidative Stress Antagonizes Wnt Signaling in Osteoblast Precursors by Diverting beta-Catenin from T Cell Factor- to Forkhead Box O-mediated Transcription J. Biol. Chem., September 14, 2007; 282(37): 27298 - 27305. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Goodman, W. Jiranek, E. Petrow, and A. W. Yasko The Effects of Medications on Bone J. Am. Acad. Ortho. Surg., August 1, 2007; 15(8): 450 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
S E Papapoulos and R C Schimmer Changes in bone remodelling and antifracture efficacy of intermittent bisphosphonate therapy: implications from clinical studies with ibandronate Ann Rheum Dis, July 1, 2007; 66(7): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Sharma, A. Bronisz, R. Hu, K. Patel, K. C. Mansky, S. Sif, and M. C. Ostrowski MITF and PU.1 Recruit p38 MAPK and NFATc1 to Target Genes during Osteoclast Differentiation J. Biol. Chem., May 25, 2007; 282(21): 15921 - 15929. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ishijima, K. Tsuji, S. R Rittling, T. Yamashita, H. Kurosawa, D. T Denhardt, A. Nifuji, Y. Ezura, and M. Noda Osteopontin is required for mechanical stress-dependent signals to bone marrow cells J. Endocrinol., May 1, 2007; 193(2): 235 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Xian Roles of Epidermal Growth Factor Family in the Regulation of Postnatal Somatic Growth Endocr. Rev., May 1, 2007; 28(3): 284 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Chavassieux, E. Seeman, and P. D. Delmas Insights into Material and Structural Basis of Bone Fragility from Diseases Associated with Fractures: How Determinants of the Biomechanical Properties of Bone Are Compromised by Disease Endocr. Rev., April 1, 2007; 28(2): 151 - 164. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. Perrien, N. S. Akel, P. K. Edwards, A. A. Carver, M. S. Bendre, F. L. Swain, R. A. Skinner, W. R. Hogue, K. M. Nicks, T. M. Pierson, et al. Inhibin A Is an Endocrine Stimulator of Bone Mass and Strength Endocrinology, April 1, 2007; 148(4): 1654 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. YOUSEFZADEH, B. LARIJANI, A. MOHAMMADIRAD, R. HESHMAT, G. DEHGHAN, R. RAHIMI, and M. ABDOLLAHI Determination of Oxidative Stress Status and Concentration of TGF-beta1 in the Blood and Saliva of Osteoporotic Subjects Ann. N.Y. Acad. Sci., December 1, 2006; 1091(1): 142 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. HADJIDAKIS and I. I. ANDROULAKIS Bone Remodeling Ann. N.Y. Acad. Sci., December 1, 2006; 1092(1): 385 - 396. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Chen, R. L. Haley, M. Hidestrand, K. Shankar, X. Liu, C. K. Lumpkin, P. M. Simpson, T. M. Badger, and M. J. J. Ronis Estradiol Protects against Ethanol-Induced Bone Loss by Inhibiting Up-Regulation of Receptor Activator of Nuclear Factor-{kappa}B Ligand in Osteoblasts J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1182 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Weisinger, R. G. Carlini, E. Rojas, and E. Bellorin-Font Bone Disease after Renal Transplantation Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1300 - 1313. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim, M. Yamazaki, L. A. Zella, N. K. Shevde, and J. W. Pike Activation of Receptor Activator of NF-{kappa}B Ligand Gene Expression by 1,25-Dihydroxyvitamin D3 Is Mediated through Multiple Long-Range Enhancers. Mol. Cell. Biol., September 1, 2006; 26(17): 6469 - 6486. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Grassi, X. Fan, J. Rahnert, M. N. Weitzmann, R. Pacifici, M. S. Nanes, and J. Rubin Bone Re/Modeling Is More Dynamic in the Endothelial Nitric Oxide Synthase(-/-) Mouse Endocrinology, September 1, 2006; 147(9): 4392 - 4399. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. J. Allison, P. Baldock, A. Sainsbury, R. Enriquez, N. J. Lee, E.-J. D. Lin, M. Klugman, M. During, J. A. Eisman, M. Li, et al. Conditional Deletion of Hypothalamic Y2 Receptors Reverts Gonadectomy-induced Bone Loss in Adult Mice J. Biol. Chem., August 18, 2006; 281(33): 23436 - 23444. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Rahman, A. Bhattacharya, and G. Fernandes Conjugated linoleic acid inhibits osteoclast differentiation of RAW264.7 cells by modulating RANKL signaling J. Lipid Res., August 1, 2006; 47(8): 1739 - 1748. [Abstract] [Full Text] [PDF] |
||||
![]() |
U.H. Lerner Bone Remodeling in Post-menopausal Osteoporosis. J. Dent. Res., July 1, 2006; 85(7): 584 - 595. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Seeman and P. D. Delmas Bone quality--the material and structural basis of bone strength and fragility. N. Engl. J. Med., May 25, 2006; 354(21): 2250 - 2261. [Full Text] [PDF] |
||||
![]() |
D. S. Perrien, S. J. Achenbach, S. E. Bledsoe, B. Walser, L. J. Suva, S. Khosla, and D. Gaddy Bone Turnover across the Menopause Transition: Correlations with Inhibins and Follicle-Stimulating Hormone J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1848 - 1854. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.J. MARTIN, J.M.W. QUINN, M.T. GILLESPIE, K.W. NG, M.A. KARSDAL, and N.A. SIMS Mechanisms Involved in Skeletal Anabolic Therapies Ann. N.Y. Acad. Sci., April 1, 2006; 1068(1): 458 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Almeida, L. Han, C. A. O'Brien, S. Kousteni, and S. C. Manolagas Classical Genotropic Versus Kinase-Initiated Regulation of Gene Transcription by the Estrogen Receptor {alpha} Endocrinology, April 1, 2006; 147(4): 1986 - 1996. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Phadke, R. R. Mercer, J. F. Harms, Y. Jia, A. R. Frost, J. L. Jewell, K. M. Bussard, S. Nelson, C. Moore, J. C. Kappes, et al. Kinetics of Metastatic Breast Cancer Cell Trafficking in Bone Clin. Cancer Res., March 1, 2006; 12(5): 1431 - 1440. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Manolagas Choreography from the Tomb: An Emerging Role of Dying Osteocytes in the Purposeful, and Perhaps Not So Purposeful, Targeting of Bone Remodeling IBMS BoneKEy, January 1, 2006; 3(1): 5 - 14. [Full Text] [PDF] |
||||
![]() |
H. Ha, J.-H. Lee, H.-N. Kim, H.-M. Kim, H. B. Kwak, S. Lee, H.-H. Kim, and Z. H. Lee {alpha}-Lipoic Acid Inhibits Inflammatory Bone Resorption by Suppressing Prostaglandin E2 Synthesis J. Immunol., January 1, 2006; 176(1): 111 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Liu, S. Wang, S. Wei, L. Sun, and X. Feng Receptor Activator of NF-{kappa}B (RANK) Cytoplasmic Motif, 369PFQEP373, Plays a Predominant Role in Osteoclast Survival in Part by Activating Akt/PKB and Its Downstream Effector AFX/FOXO4 J. Biol. Chem., December 30, 2005; 280(52): 43064 - 43072. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Young, N. Mikhalkevich, Y. Yan, D. Chen, and W.-p. Zheng Differential Regulation of Osteoblast Activity by Th Cell Subsets Mediated by Parathyroid Hormone and IFN-{gamma} J. Immunol., December 15, 2005; 175(12): 8287 - 8295. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Bellido, A. A. Ali, I. Gubrij, L. I. Plotkin, Q. Fu, C. A. O'Brien, S. C. Manolagas, and R. L. Jilka Chronic Elevation of Parathyroid Hormone in Mice Reduces Expression of Sclerostin by Osteocytes: A Novel Mechanism for Hormonal Control of Osteoblastogenesis Endocrinology, November 1, 2005; 146(11): 4577 - 4583. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bajayo, I. Goshen, S. Feldman, V. Csernus, K. Iverfeldt, E. Shohami, R. Yirmiya, and I. Bab Central IL-1 receptor signaling regulates bone growth and mass PNAS, September 6, 2005; 102(36): 12956 - 12961. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Gazzerro, V. Deregowski, S. Vaira, and E. Canalis Overexpression of Twisted Gastrulation Inhibits Bone Morphogenetic Protein Action and Prevents Osteoblast Cell Differentiation in Vitro Endocrinology, September 1, 2005; 146(9): 3875 - 3882. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Plotkin, I. Mathov, J. I. Aguirre, A. M. Parfitt, S. C. Manolagas, and T. Bellido Mechanical stimulation prevents osteocyte apoptosis: requirement of integrins, Src kinases, and ERKs Am J Physiol Cell Physiol, September 1, 2005; 289(3): C633 - C643. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P Shrader and K. R Ragucci Parathyroid Hormone (1-84) and Treatment of Osteoporosis Ann. Pharmacother., September 1, 2005; 39(9): 1511 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, E.-Y. Ahn, M. A. McKenna, H. Yeo, and J. M. McDonald Fas Binding to Calmodulin Regulates Apoptosis in Osteoclasts J. Biol. Chem., August 19, 2005; 280(33): 29964 - 29970. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Y. Han, N. K. Lee, K. H. Kim, I. W. Jang, M. Yim, J. H. Kim, W. J. Lee, and S. Y. Lee Transcriptional induction of cyclooxygenase-2 in osteoclast precursors is involved in RANKL-induced osteoclastogenesis Blood, August 15, 2005; 106(4): 1240 - 1245. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Karasik, S. Demissie, L. A. Cupples, and D. P. Kiel Disentangling the Genetic Determinants of Human Aging: Biological Age as an Alternative to the Use of Survival Measures J. Gerontol. A Biol. Sci. Med. Sci., May 1, 2005; 60(5): 574 - 587. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Broker, F. A.E. Kruyt, and G. Giaccone Cell Death Independent of Caspases: A Review Clin. Cancer Res., May 1, 2005; 11(9): 3155 - 3162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Vertino, C. M. Bula, J.-R. Chen, M. Almeida, L. Han, T. Bellido, S. Kousteni, A. W. Norman, and S. C. Manolagas Nongenotropic, Anti-Apoptotic Signaling of 1{alpha},25(OH)2-Vitamin D3 and Analogs through the Ligand Binding Domain of the Vitamin D Receptor in Osteoblasts and Osteocytes: MEDIATION BY Src, PHOSPHATIDYLINOSITOL 3-, AND JNK KINASES J. Biol. Chem., April 8, 2005; 280(14): 14130 - 14137. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Alkhiary, L. C. Gerstenfeld, E. Krall, M. Westmore, M. Sato, B. H. Mitlak, and T. A. Einhorn Enhancement of Experimental Fracture-Healing by Systemic Administration of Recombinant Human Parathyroid Hormone (PTH 1-34) J. Bone Joint Surg. Am., April 1, 2005; 87(4): 731 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schneider, L. M. Kalikin, A. C. Mattos, E. T. Keller, M. J. Allen, K. J. Pienta, and L. K. McCauley Bone Turnover Mediates Preferential Localization of Prostate Cancer in the Skeleton Endocrinology, April 1, 2005; 146(4): 1727 - 1736. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Fontana, J. L. Shew, J. O. Holloszy, and D. T. Villareal Low Bone Mass in Subjects on a Long-term Raw Vegetarian Diet Arch Intern Med, March 28, 2005; 165(6): 684 - 689. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kaabeche, H. Guenou, D. Bouvard, N. Didelot, A. Listrat, and P. J. Marie Cbl-mediated ubiquitination of {alpha}5 integrin subunit mediates fibronectin-dependent osteoblast detachment and apoptosis induced by FGFR2 activation J. Cell Sci., March 15, 2005; 118(6): 1223 - 1232. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, F. P. Ross, and S. L. Teitelbaum Unoccupied {alpha}v{beta}3 Integrin Regulates Osteoclast Apoptosis by Transmitting a Positive Death Signal Mol. Endocrinol., March 1, 2005; 19(3): 771 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohishi, Y. Matsumura, D. Aki, R. Mashima, K. Taniguchi, T. Kobayashi, T. Kukita, Y. Iwamoto, and A. Yoshimura Suppressors of Cytokine Signaling-1 and -3 Regulate Osteoclastogenesis in the Presence of Inflammatory Cytokines J. Immunol., March 1, 2005; 174(5): 3024 - 3031. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-R. Chen, L. I. Plotkin, J. I. Aguirre, L. Han, R. L. Jilka, S. Kousteni, T. Bellido, and S. C. Manolagas Transient Versus Sustained Phosphorylation and Nuclear Accumulation of ERKs Underlie Anti-Versus Pro-apoptotic Effects of Estrogens J. Biol. Chem., February 11, 2005; 280(6): 4632 - 4638. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Veldhuis, J. N. Roemmich, E. J. Richmond, A. D. Rogol, J. C. Lovejoy, M. Sheffield-Moore, N. Mauras, and C. Y. Bowers Endocrine Control of Body Composition in Infancy, Childhood, and Puberty Endocr. Rev., February 1, 2005; 26(1): 114 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsumoto, M. Kogawa, S. Wada, H. Takayanagi, M. Tsujimoto, S. Katayama, K. Hisatake, and Y. Nogi Essential Role of p38 Mitogen-activated Protein Kinase in Cathepsin K Gene Expression during Osteoclastogenesis through Association of NFATc1 and PU.1 J. Biol. Chem., October 29, 2004; 279(44): 45969 - 45979. [Abstract] [Full Text] [PDF] |
||||
![]() |
S P Conway, B Oldroyd, A Morton, J G Truscott, and D G Peckham Effect of oral bisphosphonates on bone mineral density and body composition in adult patients with cystic fibrosis: a pilot study Thorax, August 1, 2004; 59(8): 699 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. W. Goderie-Plomp, M. van der Klift, W. de Ronde, A. Hofman, F. H. de Jong, and H. A. P. Pols Endogenous Sex Hormones, Sex Hormone-Binding Globulin, and the Risk of Incident Vertebral Fractures in Elderly Men and Women: The Rotterdam Study J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3261 - 3269. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Stossi, D. H. Barnett, J. Frasor, B. Komm, C. R. Lyttle, and B. S. Katzenellenbogen Transcriptional Profiling of Estrogen-Regulated Gene Expression via Estrogen Receptor (ER) {alpha} or ER{beta} in Human Osteosarcoma Cells: Distinct and Common Target Genes for These Receptors Endocrinology, July 1, 2004; 145(7): 3473 - 3486. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Vanderschueren, L. Vandenput, S. Boonen, M. K. Lindberg, R. Bouillon, and C. Ohlsson Androgens and Bone Endocr. Rev., June 1, 2004; 25(3): 389 - 425. [Abstract] [Full Text] [PDF] |
||||
![]() |
|